GMP Cell Therapy Consumables Market Exclusive Report with Detailed Study Analysis

InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global GMP Cell Therapy Consumables Market Size, Share & Trends Analysis Report By Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), End User (Clinical, Commercial, and Research) Market Outlook And Industry Analysis 2031"

According to the latest research by InsightAce Analytic, the global GMP Cell Therapy Consumables Market Size is valued at USD 17.61 Bn in 2023 and is predicted to reach USD 137.97 Bn by the year 2031 at a 29.8% CAGR during the forecast period for 2024-2031.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1929

Cell therapy has garnered considerable attention from both researchers and medical professionals. Cell therapy consumables refer to the materials utilized in the manufacturing process of cell therapies. Drug development and discovery, a lengthy process, heavily rely on cell therapy consumables to achieve the desired outcomes.

According to the World Health Organization (WHO), approximately 10 million deaths were recorded in 2020 due to cancer, with the most prevalent types being breast, lung, colon, rectal, and prostate cancers. Numerous studies have demonstrated the potential of cell therapies to yield positive results in treating cancer, brain diseases, autoimmune disorders, and other chronic conditions. As a result, the rising incidence of chronic diseases has driven an increased focus on research and development activities.

Some of the prominent players in the GMP Cell Therapy Consumables Market are:
• Sartorius AG
• Thermo Fisher Scientific Inc
• Miltenyi Biotec BV & Co KG
• Bio-Techne Corp
• Corning Inc
• FUJIFILM Irvine Scientific Inc
• Lonza Group AG
• BPS Bioscience Inc
• Merck KGaA
• Global Life Sciences Solutions USA LLC.
• Other Prominent Players

Curious about this latest version of the report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1929

Market Dynamics:
Drivers:
Rising R&D Activities and Drug Discovery Drive Market Expansion
The growing investment in research and development (R&D) and drug discovery is significantly fueling the demand for GMP cell therapy consumables. Numerous studies have demonstrated the positive outcomes of drug therapies in effectively treating chronic conditions such as cancer, neurological disorders, autoimmune diseases, and others. As the prevalence of chronic diseases continues to rise, the need for ongoing R&D activities is expected to drive market growth in the coming years.

Partnerships and Collaborative Efforts Accelerate Market Growth
Moreover, collaboration between various biotech and pharmaceutical companies is accelerating R&D activities and the development of innovative therapies. The increasing number of drug discoveries, the rising demand for personalized medicine, and the growing utilization of GMP consumables are contributing to the expansion of the GMP cell therapy consumables market.

Challenges:
Cell therapy and drug development remain complex and costly processes. The stringent regulatory frameworks governing cell therapy applications, particularly in terms of compliance with Current Good Manufacturing Practices (CGMP), are expected to limit market growth. The U.S. Food and Drug Administration (FDA) plays a critical role in ensuring product quality by monitoring companies' adherence to CGMP standards.

Regional Trends:
In 2022, North America held the largest revenue share of the GMP cell therapy consumables market and is expected to maintain its growth during the forecast period. The United States is predicted to retain the dominant market position due to factors such as the growing number of drug discoveries, rising demand for personalized and regenerative medicine, increased government investments in cell therapy R&D, and the high prevalence of diseases like cancer, autoimmune disorders, neurological conditions, and infectious diseases.

Key developments in the market:
• In March 2023, Thermo Fisher Scientific collaborated with Arsenal Biosciences for T-Cell therapy manufacturing.
• In March 2022, FUJIFILM Irvine Scientific, Inc. acquired Shenandoah Biotechnology, Inc., a leading manufacturer of recombinant proteins. Shenandoah Biotechnology recently introduced their CTG Grade line of cytokines & growth factors manufactured according to cGMP guidelines in the company's new state-of-the-art, ISO 9001:2015 certified facility.
• In April 2022, Thermo Fisher Scientific launched the new GMP-manufactured Gibco CTS TrueCut Cas9 Protein. This product line is designed to perform synergistically across the complete workflow, from cell isolation/activation to cell engineering and development, to address cell therapy developers' manufacturing needs.
• In January 2019, Sartorius Stedim Biotech launched a new GMP platform, BIOSTAT RM TX single-use bioreactor. A new mixed system combines Sartorius's established single-use Flexsafe bag technology with the company's expertise in biopharmaceutical automation. It is developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1929

Market Segments
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2031 based on Product
• Kits
• Reagents/Molecular Biology Reagents
• Growth Factors/Cytokines and Interleukins
• Others
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2031 based on Cell Therapy
• NK Cell Therapy
• Stem Cell Therapy
• T-Cell Therapy
• Others
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2031 based on Process
• Cell Collection and Characterization/Sorting and Separation
• Cell Culture and Expansion/Preparation
• Cryopreservation
• Cell Processing and Formulation
• Cell Isolation and Activation
• Cell Distribution/Handling
• Process Monitoring and Control/Readministration/Quality Assurance
• Others
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2031 based on End User
• Clinical
• Commercial
• Research
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2031 based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America GMP Cell Therapy Consumables Market Revenue (US$ Million) by Country, 2024 to 2031
• U.S.
• Canada
Europe GMP Cell Therapy Consumables Market Revenue (US$ Million) by Country, 2024 to 2031
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific GMP Cell Therapy Consumables Market Revenue (US$ Million) by Country, 2024 to 2031
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America GMP Cell Therapy Consumables Market Revenue (US$ Million) by Country, 2024 to 2031
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa GMP Cell Therapy Consumables Market Revenue (US$ Million) by Country, 2024 to 2031
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Get more information : @
https://www.insightaceanalytic.com/report/gmp-cell-therapy-consumables-market/1929

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.